LVL Médical Groupe announces the conclusion of a FINANCIAL agreement to ensure funding of its growth over the next five years, as well as the refunding by anticipation of its Bonds maturing on 12 June 2013 (isin code FR0010616995).
Part of this funding will also be devoted to financing the buyback of shares announced in the Press Release of 15 February 2011.
Registration of this offer with the Financial Markets Authority should take place in April, subject to its approval by the General Meeting of Shareholders which is to take place on 29 March.
The refinancing of Bonds will thus allow full early repayment to take place on 13 June 2011.
Founded in 1989, LVL Médical is now a standard setter in the In-home Medical Assistance market. In order to meet the growing requirements of its patients and prescribing doctors, the Group, which originally specialised in respiratory assistance, has progressively extended its business activities to perfusion, nutrition and insulin therapy services, as well as to nursing care, in-home intensive care and nursing units (Germany). LVL Médical takes care of over 50,000 patients every day.
LVL Medical Group
Investor relations
Tel. + 33 (0)4 26 68 68 68
actionnaires@lvl-medical.fr
www.lvl-medical.com
www.lvl-medical.com
LVL Médical is quoted on Euronext Paris - Compartment B
and has only been available for long-only deferred settlement since May 26th 2010.
ISIN FR0000054686
Reuters LVLM.PA
Bloomberg LVL
Indices:
SBF 250
CAC Small 90
